Title

Treatment of Drug-Resistant Tuberculosis

Authoring Organizations

Publication Month/Year

November 15, 2019

Last Updated Month/Year

February 21, 2024

Document Type

Guideline

External Publication Status

Published

Country of Publication

US

Document Objectives

Recommendations on drugs for use in a treatment regimen for patients with multidrug-resistant tuberculosis

Target Patient Population

Patients being evaluated and treated for any form of drug-resistant TB

Inclusion Criteria

Male, Female, Adolescent, Adult, Child, Older adult

Health Care Settings

Ambulatory, Hospital

Intended Users

Nurse, nurse practitioner, physician, physician assistant

Scope

Treatment, Management

Diseases/Conditions (MeSH)

D014376 - Tuberculosis, D054908 - Extensively Drug-Resistant Tuberculosis

Keywords

multidrug-resistant (MDR), tuberculosis, Multidrug resistant, Tuberculosis

Source Citation

Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline. Am J Respir Crit Care Med 2019;200:e93–e142

Supplemental Methodology Resources

Data Supplement

Methodology

Number of Source Documents
344
Literature Search Start Date
January 1, 2009
Literature Search End Date
September 15, 2015
Specialties Involved
Infectious Disease, Pathology, Pediatrics, Pulmonology, Medical Microbiology, Pediatric Infectious Diseases, Pediatric Pulmonology, Pathology, Pediatrics, Pediatrics